New drug IY-828026 put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study tests the safety of a new drug called IY-828026 in 86 healthy adults aged 19 to 50. Participants receive either the drug or a placebo to measure side effects and how the drug moves through the body. The goal is to gather safety and dosing information, not t…
Phase: PHASE1 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 07:31 UTC